Skip to content

Clinical trials

Observational Diabetes Mellitus trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Observational Country / region: Singapore Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20092
20141
20162
20171
20182
20191
20211
20223
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status4
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S3
Singapore General Hospital3
National University Health System, Singapore2
AstraZeneca1
Bayer1
Medicine1
Merck KGaA, Darmstadt, Germany1
National University of Singapore1
Sanofi1
Singapore Chung Hwa Medical Institution1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus16
Diabetes Mellitus, Type 26
Diabetes Mellitus, Type 12
Glucose Intolerance2
Insulin Resistance2
Birth Weight1
Coronary Artery Disease1
Diabetes Complications1
Diabetes, Gestational1
Dyslipidemias1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.